Chat with us, powered by LiveChat
Main Number 646-604-2821 info@curtiscoulter.com
[et_pb_dmb_breadcrumbs disabled_on="off|off|off" _builder_version="3.13.1" body_font="|600|||||||" body_text_color="#000000" body_font_size="16" separator_text_color="#eb9605" body_font_size_tablet="51" body_line_height_tablet="2" separator_font_size_tablet="51" separator_line_height_tablet="2" link_font_size_tablet="51" link_line_height_tablet="2" linkhover_font_size_tablet="51" linkhover_line_height_tablet="2" /]

Pre-Conference Workshop Day – Tuesday, August 27th, 2019

}

12:00pm – 2:30pm

WORKSHOP A: Recent Advances in 3D Printing of Large & Small Molecule Drug Products

 

Recent Advances in 3D Printing of Large & Small Molecule Drug Products

Industrial and academic researchers have recently examined the use of 3D printing technologies to overcome the limitations associated with conventional manufacturing processes. These technologies involved fabrication of three-dimensional structures through additive joining of materials in a layer-by-layer manner. This workshop will review recent developments in 3D printing technologies for processing large and small molecule drug products into artificial tissues as well as biosensors, drug delivery devices, and medical instruments. Several topics related to 3D printing, including processing of radiographic images, development of computer models, novel 3D printing technologies, and novel materials for use in 3D printing, will be discussed. This workshop will create collaboration and discussion among the many groups involved in the development and use of 3D printing technologies, including drug development enghineers, medical device manufacturers, and clinicians. We anticipate that this workshop will facilitate future research activities, including industry-university collaborations, involving 3D printing of  large and small molecule drug for use in medicine, surgery, and dentistry.

 

Xiaoling Li, PhD

Xiaoling Li, PhD

Professor and Associate Dean/CSO, University of the Pacific / Triastek

Jae Yoo, PhD

Jae Yoo, PhD

Chief Technology Officer, Aprecia Pharmaceuticals

}

3:00pm – 5:30pm

WORKSHOP B: Oral Controlled Release Solid Dosage Forms

 

Oral Controlled Release Solid Dosage forms

During this intensive workshop, examples from industry will cover developing new product and technology offerings for modified release drug delivery, types of modified release and formulation aspects and considerations. Additionally, the workshop will cover hot melt extrusion focused on engineering aspects, manufacturing considerations, type of polymers and how things are analyzed.

 

Nasrin Mahmoudi, PhD

Nasrin Mahmoudi, PhD

Pharmaceutical Application TS&D Manager, DuPont Nutrition & Health

Tony Listro

Tony Listro

Vice President, Technical Business Development, Foster Delivery Science

 

Main Summit Day One – Wednesday, August 28th, 2019

 

}

7:30am – 8:55am

Registration Opens & Continental Breakfast for Summit Participants

}

8:55am – 9:05am

Collaboration is King! Ice Breaker

For today’s drug manufacturer, the idea of collaboration is one that should never leave the table.  Successful organizations will ensure that their internal departments are working hand-in-hand with one another.  And, even more successful companies know that there could be huge benefits to reap by collaborating with others across the healthcare ecosystem.  To instill this idea of collaborating for success, we are going to play a fun little ice-breaker game.

}

9:05am – 9:10am

Welcome and Chairperson’s Introduction & Opening Remarks

Rakesh Dixit, PhD

Rakesh Dixit, PhD

Vice President, R&D, Head Biologics Safety Assessment, AstraZeneca

}

9:10am – 9:50am

Developing Advanced Drug Delivery Systems to Better Harness effects of Cancer Immunotherapy

Michael Mitchell, PhD

Michael Mitchell, PhD

Skirkanich Assistant Professor of Innovation, University of Pennsylvania

}

9:50am – 10:30am

DEP Drug Delivery: Developing Enhanced Therapies

David Owen, PhD

David Owen, PhD

Vice President, Research, Starpharma

}

10:30am – 11:00am

Morning Networking & Refreshment Break in Exhibit Hall

}

11:00am – 11:40am

Examining Microsphere Drug Release and Impact of Formulation and Process Factors

Daniel Wu, PhD

Daniel Wu, PhD

Senior Director, Technical Operations, Bausch Health

}

11:40am – 12:20pm

Selection fo Clinically Relevant Forms & Formulations using In Vitro Analysis & Pre-Clinical Models

Phillip Snyder, PhD

Phillip Snyder, PhD

Associate Director, Preclinical and Pharmaceutical Sciences, Vertex Pharmaceuticals

}

12:20pm – 12:50pm

PANEL SESSION: Exploring Innovative Collaborations to Support The Next Generation of Drug Products

Rakesh Dixit, PhD

Rakesh Dixit, PhD

Vice President, R&D, Head Biologics Safety Assessment, AstraZeneca

Xiaoling Li, PhD

Xiaoling Li, PhD

Professor and Associate Dean/CSO, University of the Pacific / Triastek

Laszlo Otvos, PhD

Laszlo Otvos, PhD

Professor, Semmelweis Medical School

David Owen, PhD

David Owen, PhD

Vice President, Research, Starpharma

Scott Shandler, PhD

Scott Shandler, PhD

Founder & Chief Executive Officer, Longevity Biotech

}

12:30pm – 2:00pm

Networking Lunch in the Exhibit Hall

6th Controlled & Modified Drug Release Stream

4th Peptide Drug Design & Delivery Stream

}

2:00pm – 2:45pm

Combining In-Vivo Animal Models with Physiologically Based Pharmacokinetics (PBPK) Modeling to Optimize Oral Controlled Release Dosage Forms

Wen Lin, PhD

Wen Lin, PhD

Senior Director, Senior Investigator I, Novartis

Nanomedicines: Innovations in Delivery of Anti-Cancer Biologics

Rakesh Dixit, PhD

Rakesh Dixit, PhD

Vice President, R&D, Head Biologics Safety Assessment, AstraZeneca

}

2:45pm – 3:30pm

Nanoparticle Formulation Modalities: Light-Scattering Tools for Screening and Characterization

Daniel Some, PhD

Daniel Some, PhD

Principle Scientist, Marketing, Wyatt Technology

Fast Forward to Clinic with an Optimized Adiponectin Receptor Agonist Peptide

Laszlo Otvos, PhD

Laszlo Otvos, PhD

Professor, Semmelweis Medical School

}

3:30pm – 4:00pm

Afternoon Networking & Refreshment Break in Exhibit Hall

}

4:00pm – 4:45pm

Modeling Zero-order Drug Release Kinetics in Controlled Release Oral dosage forms

Kamal Jonnalagadda, PhD

Kamal Jonnalagadda, PhD

Professor & Director, Pharmaceutics Graduate Program, Philadelphia College of Pharmacy, USciences

Non-Clinical Peptide Product Development: Regulatory Aspects with a focus on Toxicology

Mayur Mitra, PhD

Mayur Mitra, PhD

Senior Scientist, Toxicologist and Pharmacology Sub-team Leader, Safety Assessment, Genentech

}

4:45pm – 5:30pm

Nucleic Acid Delivery for Enabling MRNA: Enabling the next Generation of Therapeutics

Venkata	Krishnamurthy, PhD

Venkata Krishnamurthy, PhD

Associate Principal Scientist, AstraZeneca

Nanoparticle and Microparticle Formulations of Peptides and other Biologics through Flash NanoPrecipitation

Robert Pagels, PhD

Robert Pagels, PhD

Lead Scientist, Optimeos Life Sciences

}

5:35pm

Chair’s Closing Remarks, Drinks Reception and End of Day One

 

Main Summit Day Two – Thursday, August 29th, 2019

 

}

8:00am – 8:55am

Continental Breakfast for Conference Participants

}

9:05am – 9:10am

Chairperson’s Introduction & Opening Remarks

}

9:00am – 9:45am

Utilizing Biopharmaceutical Modeling for Particle size Specification of Oral Extended Release Products

Dabing Chen, PhD

Dabing Chen, PhD

Principal Scientist, Boehringer Ingelheim

}

9:45am – 10:30am

In Situ Forming Injectable Hydrogel Formulations for Controlled Delivery of Peptides and Proteins

Yingkai Liang, PhD

Yingkai Liang, PhD

Senior Research Scientist, Formulation Development, Merck & Co.

}

10:30am - 11:00am

Morning Networking & Refreshment Break in Exhibit Hall

}

11:00am – 11:40am

Protein Stabilization in Solid Dose Formulations

Eric Munson, PhD

Eric Munson, PhD

Dane O. Kildsig Chair in Industrial and Physical Pharmacy, Department Head, Department of Industrial and Physical Pharmacy, Purdue University

}

11:40am – 12:20pm

Preclinical Studies of an Intranasal Prodrug/Enzyme Formulation to Treat Seizure Emergencies

Ronald Siegel, PhD

Ronald Siegel, PhD

Professor, Department of Pharmaceutics, University of Minnesota

}

12:20pm – 1:00pm

Advances in 3D Manufacture of Sustained Release Oral Drug Products

Xiaoling Li, PhD

Xiaoling Li, PhD

Professor and Associate Dean/CSO, University of the Pacific / Triastek

}

1:00pm – 2:00pm

Networking Lunch in the Exhibit Hall

}

2:00pm – 2:40pm

Drug Release Simulations and Advanced Characterization of Long Acting Implants

Daniel Skomski, PhD

Daniel Skomski, PhD

Senior Scientist, Merck & Co.

}

2:40pm – 3:20pm

Enabled Formulations Bridging Discovery and Development for Modified Release Drug Products

Ruchit Trivedi, PhD

Ruchit Trivedi, PhD

Associate Director, Formulation, Bioduro

}

3:20pm – 3:40pm

Afternoon Networking & Refreshment Break in Exhibit Hall

}

3:40pm – 4:10pm

PANEL: Developing Metabolically Stable Peptide-Like Therapeutics with Unique Molecular Biology Properties

Laszlo Otvos, PhD

Laszlo Otvos, PhD

Professor, Semmelweis Medical School

Rakesh Dixit, PhD

Rakesh Dixit, PhD

Vice President, R&D, Head Biologics Safety Assessment, AstraZeneca

Scott Shandler, PhD

Scott Shandler, PhD

Founder & Chief Executive Officer, Longevity Biotech

}

4:10pm – 4:40pm

Advances in 3D Printing and Bioprocessing for Tissue Engineering

Mahima Singh, Pharm.D

Mahima Singh, Pharm.D

Pharmaceutical Sciences Researcher, University of the Sciences

}

4:40m – 5:10pm

Expediting Peptide Product Development for Precision Medicine

Chong-Hui Gu, PhD

Chong-Hui Gu, PhD

Head of CMC, Agios Pharmaceuticals

}

5:10pm

Chair’s Wrap-up & Conference Concludes

Pin It on Pinterest

Share This